Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EQU-001 add-on therapy for focal seizures
NL-OMON59322Phase 2Completed
- Sponsor
- Equilibre Biopharmaceuticals
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ivermectin, sponsored by Equilibre Biopharmaceuticals. Started Apr 2023; status: completed.
02
Drugs
ivermectin
Beyond the preview
Go deeper on NL-OMON59322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59322.